Our previous study showed that administering whole tumor cell vaccine expressing IL-21 in the GPI-anchored form (B16F10/GPI-IL-21) induced protective anti-melanoma immunity in a B16F10 cell transplantable mouse model. This evidence concerns the gene IL21 and melanoma.